Friday, September 4, 2026
26.9 C
Bengaluru

Doctors Day with a Difference

[wpfilebase tag=file id=113 tpl=download-button /]

Inside this Issue

1. Editorial: Doctor’s Day with a Difference!

MedicinMan reports on a unique celebration of the special day in Mangaluru, Karnataka, organized by a prominent city surgeon and professor and honoring the work of anganwadi workers, medical representatives and the District Health Officer.

2. Briefing the Design Agency: A Skill Oft-Neglected by Pharma Brand Managers by Vivek Hattangadi

The design brief can make or break a brand campaign; here’s how to get it right.

3. Indian Pharma Highlights for June 2018 by IQVIA

The Indian pharma market clocked 10,460 Crores for month of June with a robust growth at 12.8%. Here are the biggest winners.

4. Pharma’s Silver Lining Continues to Broaden by Salil Kallianpur

Salil Kallianpur, Executive Editor, MedicinMan, comments on the IQVIA numbers for June 2018

5. Pharmacology Refresher: Drugs Acting on the Nitric Oxide Pathway by Dr. Anand Lakhar

The nitric oxide pathway in the human body is key to the treatment of a variety of diseases from angina to erectile dysfunction

6. Philips Launches India’s 1st Future Health Index by Press Release

The FHI is “a research-based platform that helps to determine the readiness of countries to address global health challenges”

7. Book Review: Encyclopedia of Nobel Laureates

Download the issue here: PDF

Hot this week

Pharmacy of the World Pricing Paradox

India occupies an extraordinary position in global pharmaceuticals. It...

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

India has two very different pharmaceutical regulators living inside...

MedicinMan Pharma Pulse: August 2026

🚀 The Mega-Merger That Wasn't Early August saw the...

GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?

STOP PRESS August 10, 2026: Regulatory Authorisation — The UK...

How To See Dr Reddy’s Nestle In The Wellness Shift

GLP-1 medicines such as semaglutide and tirzepatide are changing...

Topics

Pharmacy of the World Pricing Paradox

India occupies an extraordinary position in global pharmaceuticals. It...

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

India has two very different pharmaceutical regulators living inside...

MedicinMan Pharma Pulse: August 2026

🚀 The Mega-Merger That Wasn't Early August saw the...

GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?

STOP PRESS August 10, 2026: Regulatory Authorisation — The UK...

How To See Dr Reddy’s Nestle In The Wellness Shift

GLP-1 medicines such as semaglutide and tirzepatide are changing...

How To Power The India Biopharma Regulatory Revolution Now

Beyond the Pharmacy of the World: Why India's Biopharma...

Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?

Something remarkable has happened in the Indian pharmaceutical market....

Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?

C-Suite Executive Summary India stands at a pivotal juncture in...
spot_img

Related Articles

spot_imgspot_img